BOULDER, Colo., Sept. 25, 2018 /PRNewswire/ -- Array
BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief
Executive Officer, Ron Squarer, will
speak at the 2018 Cantor Global Healthcare Conference in
New York. The public is welcome to
participate in the conference through a webcast on the Array
BioPharma website.
Event:
|
Cantor Global
Healthcare Conference
|
Presenter:
|
Ron Squarer, Chief
Executive Officer, Array BioPharma
|
Date:
|
Tuesday, October 2,
2018
|
Time:
|
9:45 a.m. Eastern
Time
|
Webcast:
|
http://wsw.com/webcast/cantor7/arry/
|
About Array BioPharma
Array BioPharma Inc. is a fully-integrated, biopharmaceutical
company focused on the discovery, development and commercialization
of transformative and well-tolerated targeted small molecule drugs
to treat patients afflicted with cancer and other high-burden
diseases. Array markets in the United
States BRAFTOVI® (encorafenib) capsules in
combination with MEKTOVI® (binimetinib) tablets for the
treatment of patients with unresectable or metastatic melanoma with
a BRAFV600E or BRAFV600K
mutation. Array's lead clinical programs, encorafenib and
binimetinib, are being investigated in over 30 clinical trials
across a number of solid tumor indications, including a Phase 3
trial in BRAF-mutant colorectal cancer. Array's pipeline
includes several additional programs being advanced by Array or
current license-holders, including selumetinib (partnered with
AstraZeneca), larotrectinib (partnered with Loxo Oncology),
ipatasertib (partnered with Genentech), tucatinib (partnered with
Seattle Genetics) and ARRY-797, all of which are currently in
registration trials. Ganovo® (danoprevir, partnered with
Roche) was recently approved in China for the treatment of viral hepatitis C.
For more information on Array, please visit www.arraybiopharma.com
or follow @arraybiopharma on Twitter and LinkedIn.
CONTACT:
Andrea N. Flynn, Ph.D.
Senior Director, Investor Relations & Corporate
Communications
(303) 381-6600
ir@arraybiopharma.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-2018-cantor-global-healthcare-conference-300718607.html
SOURCE Array BioPharma Inc.